Chemed Corporation Stockholders Elect Directors, Ratify Accountants, and Declare Quarterly Dividend

Chemed Corporation stockholders elected nine directors, ratified PricewaterhouseCoopers as accountants, and declared a quarterly dividend.

Quiver AI Summary

Chemed Corporation held its 2026 annual stockholders’ meeting, where shareholders elected nine directors and ratified PricewaterhouseCoopers LLP as the independent accountants for the year. However, a non-binding proposal regarding executive compensation did not pass. The Board of Directors subsequently declared a quarterly cash dividend of 60 cents per share, marking the company's 220th consecutive quarterly dividend. This dividend will be paid on June 16, 2026, to shareholders of record by May 28, 2026. Chemed operates two subsidiaries, VITAS Healthcare, the largest provider of hospice care in the U.S., and Roto-Rooter, a leading plumbing and drain cleaning service. The press release includes forward-looking statements with a caution that actual results may differ from predictions.

Potential Positives

Stockholders elected a slate of nine directors, indicating strong support for the company's leadership and governance.
The continuation of PricewaterhouseCoopers LLP as independent accountants reinforces investor confidence in the company's financial oversight.
The declaration of a quarterly cash dividend of 60 cents per share reflects the company's commitment to returning value to shareholders and underscores its long-term financial stability, marked by 220 consecutive quarterly dividends.

Potential Negatives

The non-binding proposal on Chemed’s executive compensation was not approved, which could indicate dissatisfaction among stockholders regarding executive pay practices.
The reliance on a third-party firm (PricewaterhouseCoopers LLP) for independent accounting could raise concerns about financial oversight, especially given the recent rejection of the executive compensation proposal.

FAQ

What was the outcome of Chemed Corporation's 2026 annual stockholders’ meeting?

Stockholders elected nine directors and ratified PricewaterhouseCoopers LLP as independent accountants for 2026.

What dividend did Chemed Corporation declare?

Chemed declared a quarterly cash dividend of 60 cents per share, payable on June 16, 2026.

How long has Chemed been paying quarterly dividends?

This dividend marks the 220th consecutive quarterly dividend in Chemed's 55 years as a public company.

What are Chemed Corporation’s main subsidiaries?

Chemed operates VITAS Healthcare, the largest hospice provider, and Roto-Rooter, the leading plumbing services provider.

Is the executive compensation proposal from Chemed approved?

No, the non-binding proposal on Chemed's executive compensation was not approved by stockholders.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$CHE Insider Trading Activity

$CHE insiders have traded $CHE stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CHE stock by insiders over the last 6 months:

KEVIN J MCNAMARA (president and CEO) has made 0 purchases and 4 sales selling 7,500 shares for an estimated $3,077,775.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CHE Revenue

$CHE had revenues of $657.5M in Q1 2026. This is an increase of 1.63% from the same period in the prior year.

You can track CHE financials on Quiver Quantitative's CHE stock page.

You can access data on CHE stock through the Quiver Quantitative API.

$CHE Hedge Fund Activity

We have seen 227 institutional investors add shares of $CHE stock to their portfolio, and 315 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO removed 5,549,852 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $2,096,401,094
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC removed 279,511 shares (-60.2%) from their portfolio in Q1 2026, for an estimated $105,582,485
TWO SIGMA INVESTMENTS, LP added 191,664 shares (+174.4%) to their portfolio in Q1 2026, for an estimated $72,399,159
NEUBERGER BERMAN GROUP LLC removed 170,692 shares (-41.4%) from their portfolio in Q1 2026, for an estimated $64,477,196
VICTORY CAPITAL MANAGEMENT INC added 109,033 shares (+1260.2%) to their portfolio in Q4 2025, for an estimated $46,650,859
AMERIPRISE FINANCIAL INC removed 107,617 shares (-89.8%) from their portfolio in Q1 2026, for an estimated $40,651,245
CITADEL ADVISORS LLC added 95,661 shares (+518.3%) to their portfolio in Q1 2026, for an estimated $36,134,986

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CHE Price Targets

Multiple analysts have issued price targets for $CHE recently. We have seen 3 analysts offer price targets for $CHE in the last 6 months, with a median target of $475.0.

Here are some recent targets:

Ben Hendrix from RBC Capital set a target price of $436.0 on 04/27/2026
Michael Wiederhorn from Oppenheimer set a target price of $500.0 on 02/27/2026
Brian Tanquilut from Jefferies set a target price of $475.0 on 01/22/2026

Full Release

CINCINNATI, May 18, 2026 (GLOBE NEWSWIRE) -- Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company’s 2026 annual stockholders’ meeting.

Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company’s independent accountants for 2026. The non-binding proposal on Chemed’s executive compensation was not approved.

Dividend Declared

Following the stockholders’ meeting, Chemed’s Board of Directors declared a quarterly cash dividend of 60 cents per share on the Company’s capital stock, payable on June 16, 2026, to stockholders of record as of May 28, 2026. This represents the 220th consecutive quarterly dividend paid to stockholders in Chemed’s 55 years as a public company.

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care, and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.

Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.

CONTACT:	Michael D. Witzeman
	(513) 762-6714